US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quoin Pharmaceuticals

6.22

+0.10001.63%

Post-market: 5.87-0.3500-5.63%16:19 EDT

Volume:564.22K

Turnover:3.40M

Market Cap:12.49M

PE:-0.73

High:6.55

Open:5.45

Low:5.43

Close:6.12

52wk High:41.80

52wk Low:3.25

Shares:2.01M

Float Shares:1.36M

Volume Ratio:0.09

T/O Rate:41.50%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-8.5210

EPS(LYR):-14.7963

ROE:-575.73%

ROA:-114.60%

PB:3.18

PE(LYR):-0.42

Loading ...

Overview Company News Filings

Quoin Pharmaceuticals Provides Clinical And Regulatory Update For Qrx009 Topical Rapamycin Development Programs

Quoin plans investigator-led trial of QRX009 topical rapamycin in pachyonychia congenita

Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs

Quoin’s QRX003 Trial Moves Forward In Rare Skin Disease, Keeping QNRX On Investor Watch

Financing Covenants Put Quoin Pharmaceuticals at Heightened Risk of Funding Shortfall and Program Delays

Quoin Pharmaceuticals Ltd : Alliance Global Partners Raises Target Price to $35 From $25

THOMSON REUTERS

Quoin Pharmaceuticals Ltd reports results for the quarter ended December 31 - Earnings Summary

Quoin Pharmaceuticals Q4 EPS $(1.74) Beats $(4.02) Estimate

Benzinga Earnings

Quoin Pharmaceuticals FY2025 net loss widens 76.34% to $15.8 million; cash climbs 14.85% to $18.7 million

Press Release: Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

Market Sentiment Around Loss-Making Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX)

Simply Wall St.

Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM

Quoin Pharmaceuticals Provides Clinical And Regulatory Update From Constructive Type C Meeting With U.S. FDA For Qrx003 In Netherton Syndrome

Quoin Pharmaceuticals rises on FDA feedback; single Phase 3 trial may support QRX003 approval in Netherton syndrome

Quoin Pharmaceuticals Ltd expected to post a loss of $3.34 a share - Earnings Preview

Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026

Quoin Pharmaceuticals begins two late-stage whole-body trials of QRX003 4% lotion for Netherton Syndrome

Quoin Pharmaceuticals receives U.S. Fast Track Designation to QRX003

FDA grants Fast Track designation to Quoin's QRX003 for Netherton syndrome treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/QNRX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"QNRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNRX\",,,,,undefined,":{"symbol":"QNRX","market":"US","secType":"STK","nameCN":"Quoin Pharmaceuticals","latestPrice":6.22,"timestamp":1788206400000,"preClose":6.12,"halted":0,"volume":564218,"hourTrading":{"tag":"盘后","latestPrice":5.87,"preClose":6.22,"latestTime":"16:19 EDT","volume":1451,"amount":8717.4334447,"timestamp":1788207567903,"change":-0.35,"changeRate":-0.05627,"amplitude":0.057878},"delay":0,"changeRate":0.016339869281045694,"floatShares":1359700,"shares":2008400,"eps":-8.521029,"marketStatus":"Post-Mkt","change":0.1,"latestTime":"08-31 16:19:34 EDT","open":5.45,"high":6.55,"low":5.43,"amount":3400186.710769,"amplitude":0.183007,"askPrice":6.21,"askSize":8012,"bidPrice":5.86,"bidSize":50,"shortable":0,"etf":0,"ttmEps":-8.521029,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"adrRate":35,"exchange":"NASDAQ","adjPreClose":6.12,"preHourTrading":{"tag":"盘前","latestPrice":5.52,"preClose":6.12,"latestTime":"09:29 EDT","volume":43785,"amount":242714.96676,"timestamp":1788182969829,"change":-0.6,"changeRate":-0.098039,"amplitude":0.116585},"postHourTrading":{"tag":"盘后","latestPrice":5.87,"preClose":6.22,"latestTime":"16:19 EDT","volume":1451,"amount":8717.4334447,"timestamp":1788207567903,"change":-0.35,"changeRate":-0.05627,"amplitude":0.057878},"volumeRatio":0.090681},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNRX\",,,,,undefined,":{"symbol":"QNRX","floatShares":1359700,"roa":"-114.60%","roe":"-575.73%","lyrEps":-14.79626,"volumeRatio":0.090681,"shares":2008400,"dividePrice":0,"high":6.55,"amplitude":0.183007,"preClose":6.12,"low":5.43,"week52Low":3.25,"pbRate":"3.18","week52High":41.8,"institutionHeld":0,"latestPrice":6.22,"committee":-0.987596,"eps":-8.521029,"divideRate":0,"volume":564218,"delay":0,"ttmEps":-8.521029,"open":5.45,"prevYearClose":14.43,"prevWeekClose":6.12,"prevMonthClose":4.45,"prevQuarterClose":4.84,"fiveDayClose":5.42,"twentyDayClose":4.45,"sixtyDayClose":4.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QNRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"QNRX","fiscalQuarterEnding":"2026/06","expectedEps":-1.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-1.9},{"market":"US","date":"2026-05-07","symbol":"QNRX","fiscalQuarterEnding":"2026/03","expectedEps":-1.8,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-1.77},{"market":"US","date":"2026-03-26","symbol":"QNRX","fiscalQuarterEnding":"2025/12","expectedEps":-6.42,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"pre","actualEps":-14.8},{"market":"US","date":"2025-11-06","symbol":"QNRX","fiscalQuarterEnding":"2025/09","expectedEps":-6.36,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-6.71},{"market":"US","date":"2025-08-07","symbol":"QNRX","fiscalQuarterEnding":"2025/06","expectedEps":-6.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-6.28}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QNRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QNRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1781582400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QNRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QNRX","date":"2026-08-28","current":-0.729959,"percent":0.377853,"low":-17.346367,"twenty":-0.733427,"median":-0.499372,"eighty":-0.34618,"high":-0.000007,"avg":-0.749302,"sd":1.461005,"marketCap":10353389},"quantilePoints":[{"date":"2021-10-29","current":-17.346367,"twenty":-17.346367,"median":-17.346367,"eighty":-17.346367,"marketCap":97148313},{"date":"2021-11-05","current":-12.667021,"twenty":-16.958905,"median":-15.73691,"eighty":-14.60433,"marketCap":70941637},{"date":"2021-11-12","current":-8.658281,"twenty":-16.765174,"median":-12.667021,"eighty":-10.28264,"marketCap":48490695},{"date":"2021-11-19","current":-7.615115,"twenty":-14.708646,"median":-10.506176,"eighty":-8.241015,"marketCap":42648443},{"date":"2021-11-26","current":-3.943296,"twenty":-14.625193,"median":-8.598672,"eighty":-7.442247,"marketCap":37807719},{"date":"2021-12-03","current":-2.811666,"twenty":-13.054483,"median":-8.241015,"eighty":-3.931109,"marketCap":26957822},{"date":"2021-12-10","current":-3.055402,"twenty":-11.760956,"median":-7.592761,"eighty":-3.245167,"marketCap":29294723},{"date":"2021-12-17","current":-1.862838,"twenty":-10.890658,"median":-4.02164,"eighty":-3.025805,"marketCap":17860600},{"date":"2021-12-23","current":-1.549649,"twenty":-10.461469,"median":-3.943296,"eighty":-2.794256,"marketCap":16525228},{"date":"2021-12-31","current":-1.424425,"twenty":-9.308025,"median":-3.294786,"eighty":-1.787652,"marketCap":15189856},{"date":"2022-01-07","current":-1.627915,"twenty":-8.58675,"median":-3.203384,"eighty":-1.577825,"marketCap":17359836},{"date":"2022-01-14","current":-1.267895,"twenty":-8.485414,"median":-3.107631,"eighty":-1.488603,"marketCap":13520641},{"date":"2022-01-21","current":-1.0331,"twenty":-8.366195,"median":-2.876952,"eighty":-1.447905,"marketCap":11016819},{"date":"2022-01-28","current":-0.970488,"twenty":-8.163523,"median":-2.768142,"eighty":-1.377466,"marketCap":10349133},{"date":"2022-02-04","current":-1.111365,"twenty":-7.874416,"median":-1.976001,"eighty":-1.235023,"marketCap":11851426},{"date":"2022-02-11","current":-1.085306,"twenty":-7.597232,"median":-1.674874,"eighty":-1.127775,"marketCap":11573542},{"date":"2022-02-18","current":-1.061713,"twenty":-7.314087,"median":-1.573129,"eighty":-1.113525,"marketCap":11321943},{"date":"2022-02-25","current":-0.865099,"twenty":-6.348012,"median":-1.498777,"eighty":-1.105103,"marketCap":9225287},{"date":"2022-03-04","current":-0.904422,"twenty":-4.019899,"median":-1.479211,"eighty":-1.071673,"marketCap":9644618},{"date":"2022-03-11","current":-1.163952,"twenty":-3.999007,"median":-1.447905,"eighty":-1.061713,"marketCap":12412205},{"date":"2022-03-18","current":-1.163952,"twenty":-3.931109,"median":-1.416599,"eighty":-1.037796,"marketCap":12412205},{"date":"2022-03-25","current":-1.148223,"twenty":-3.765718,"median":-1.381379,"eighty":-1.057606,"marketCap":12244472},{"date":"2022-04-01","current":-1.053848,"twenty":-3.297397,"median":-1.299201,"eighty":-1.053848,"marketCap":11238077},{"date":"2022-04-08","current":-0.928015,"twenty":-3.283469,"median":-1.222936,"eighty":-1.035677,"marketCap":9896217},{"date":"2022-04-14","current":-0.476722,"twenty":-3.255613,"median":-1.205283,"eighty":-1.00962,"marketCap":10231682},{"date":"2022-04-22","current":-0.410293,"twenty":-3.203384,"median":-1.163952,"eighty":-0.975203,"marketCap":8805956},{"date":"2022-04-29","current":-0.313073,"twenty":-3.185975,"median":-1.153274,"eighty":-0.954835,"marketCap":6719363},{"date":"2022-05-06","current":-0.308697,"twenty":-3.15986,"median":-1.132494,"eighty":-0.920151,"marketCap":6625433},{"date":"2022-05-13","current":-0.243519,"twenty":-3.055402,"median":-1.120697,"eighty":-0.880828,"marketCap":5226544},{"date":"2022-05-20","current":-0.246137,"twenty":-2.907419,"median":-1.111365,"eighty":-0.857235,"marketCap":5282735},{"date":"2022-05-27","current":-0.275987,"twenty":-2.846486,"median":-1.107451,"eighty":-0.468907,"marketCap":5310410},{"date":"2022-06-03","current":-0.26812,"twenty":-2.81863,"median":-1.087972,"eighty":-0.44468,"marketCap":5159040},{"date":"2022-06-10","current":-0.203983,"twenty":-2.776847,"median":-1.085306,"eighty":-0.385285,"marketCap":3924940},{"date":"2022-06-17","current":-0.152291,"twenty":-2.489587,"median":-1.07351,"eighty":-0.319364,"marketCap":2930308},{"date":"2022-06-24","current":-0.155212,"twenty":-2.221478,"median":-1.061713,"eighty":-0.298542,"marketCap":2986515},{"date":"2022-07-01","current":-0.267305,"twenty":-1.953368,"median":-1.056579,"eighty":-0.277405,"marketCap":5143349},{"date":"2022-07-08","current":-0.231074,"twenty":-1.787652,"median":-1.053848,"eighty":-0.273302,"marketCap":4446216},{"date":"2022-07-15","current":-0.178755,"twenty":-1.674874,"median":-1.039542,"eighty":-0.267462,"marketCap":3439525},{"date":"2022-07-22","current":-0.183115,"twenty":-1.65609,"median":-1.030254,"eighty":-0.25072,"marketCap":3523416},{"date":"2022-07-29","current":-0.155517,"twenty":-1.615393,"median":-0.994864,"eighty":-0.244988,"marketCap":2992387},{"date":"2022-08-05","current":-1.0024,"twenty":-1.577825,"median":-0.983067,"eighty":-0.2438,"marketCap":19287705},{"date":"2022-08-12","current":-0.905761,"twenty":-1.530865,"median":-0.979135,"eighty":-0.244988,"marketCap":17428209},{"date":"2022-08-19","current":-1.261787,"twenty":-1.49956,"median":-0.983067,"eighty":-0.24634,"marketCap":22172308},{"date":"2022-08-26","current":-1.00506,"twenty":-1.494864,"median":-1.00373,"eighty":-0.247189,"marketCap":17661059},{"date":"2022-09-02","current":-0.83846,"twenty":-1.488603,"median":-0.983067,"eighty":-0.248209,"marketCap":14733547},{"date":"2022-09-09","current":-1.015985,"twenty":-1.47295,"median":-0.985942,"eighty":-0.249617,"marketCap":17853027},{"date":"2022-09-16","current":-0.999598,"twenty":-1.447905,"median":-1.000999,"eighty":-0.2541,"marketCap":17565075},{"date":"2022-09-23","current":-0.80537,"twenty":-1.447905,"median":-0.994135,"eighty":-0.255867,"marketCap":14152083},{"date":"2022-09-30","current":-0.61506,"twenty":-1.446166,"median":-0.983139,"eighty":-0.262906,"marketCap":10807926},{"date":"2022-10-07","current":-0.604028,"twenty":-1.436253,"median":-0.98189,"eighty":-0.267383,"marketCap":10614062},{"date":"2022-10-14","current":-0.471638,"twenty":-1.42286,"median":-0.968913,"eighty":-0.267782,"marketCap":8287692},{"date":"2022-10-21","current":-0.562656,"twenty":-1.413468,"median":-0.966397,"eighty":-0.2688,"marketCap":9887072},{"date":"2022-10-28","current":-0.529559,"twenty":-1.393119,"median":-0.950476,"eighty":-0.271699,"marketCap":9305479},{"date":"2022-11-04","current":-0.485429,"twenty":-1.358698,"median":-0.943659,"eighty":-0.272858,"marketCap":8530023},{"date":"2022-11-11","current":-0.479672,"twenty":-1.345188,"median":-0.923004,"eighty":-0.274906,"marketCap":9208547},{"date":"2022-11-18","current":-0.459476,"twenty":-1.332632,"median":-0.91334,"eighty":-0.276144,"marketCap":8820819},{"date":"2022-11-25","current":-0.462,"twenty":-1.299201,"median":-0.906739,"eighty":-0.276772,"marketCap":8869285},{"date":"2022-12-02","current":-0.441804,"twenty":-1.267895,"median":-0.903164,"eighty":-0.277827,"marketCap":8481557},{"date":"2022-12-09","current":-0.393836,"twenty":-1.261787,"median":-0.893083,"eighty":-0.277839,"marketCap":7560702},{"date":"2022-12-16","current":-0.386263,"twenty":-1.226868,"median":-0.869031,"eighty":-0.278907,"marketCap":7415304},{"date":"2022-12-23","current":-0.333246,"twenty":-1.219003,"median":-0.857235,"eighty":-0.28331,"marketCap":6397517},{"date":"2022-12-30","current":-0.358492,"twenty":-1.214288,"median":-0.83846,"eighty":-0.285895,"marketCap":6882177},{"date":"2023-01-06","current":-0.366066,"twenty":-1.203717,"median":-0.830267,"eighty":-0.294872,"marketCap":7027575},{"date":"2023-01-13","current":-0.419082,"twenty":-1.196726,"median":-0.751587,"eighty":-0.305389,"marketCap":8045362},{"date":"2023-01-20","current":-0.388787,"twenty":-1.192762,"median":-0.704699,"eighty":-0.310447,"marketCap":7463770},{"date":"2023-01-27","current":-0.393836,"twenty":-1.178108,"median":-0.684013,"eighty":-0.314277,"marketCap":7560702},{"date":"2023-02-03","current":-0.59078,"twenty":-1.163952,"median":-0.661949,"eighty":-0.317723,"marketCap":11341538},{"date":"2023-02-10","current":-0.421607,"twenty":-1.163758,"median":-0.631609,"eighty":-0.320717,"marketCap":8093828},{"date":"2023-02-17","current":-0.353443,"twenty":-1.161409,"median":-0.60749,"eighty":-0.323804,"marketCap":6785245},{"date":"2023-02-24","current":-0.118656,"twenty":-1.156304,"median":-0.591888,"eighty":-0.313675,"marketCap":2277903},{"date":"2023-03-03","current":-0.281484,"twenty":-1.14665,"median":-0.562656,"eighty":-0.29262,"marketCap":5403806},{"date":"2023-03-10","current":-0.522124,"twenty":-1.138785,"median":-0.550992,"eighty":-0.287367,"marketCap":4898302},{"date":"2023-03-17","current":-0.593625,"twenty":-1.130921,"median":-0.551624,"eighty":-0.29122,"marketCap":5569088},{"date":"2023-03-24","current":-0.65651,"twenty":-1.124629,"median":-0.575443,"eighty":-0.294825,"marketCap":6159049},{"date":"2023-03-31","current":-0.60057,"twenty":-1.123056,"median":-0.592995,"eighty":-0.300426,"marketCap":5634244},{"date":"2023-04-06","current":-0.603601,"twenty":-1.116764,"median":-0.60057,"eighty":-0.300426,"marketCap":5662676},{"date":"2023-04-14","current":-0.560679,"twenty":-1.116764,"median":-0.592742,"eighty":-0.308697,"marketCap":5260010},{"date":"2023-04-21","current":-0.580997,"twenty":-1.111365,"median":-0.593625,"eighty":-0.313073,"marketCap":5450622},{"date":"2023-04-28","current":-0.649313,"twenty":-1.111365,"median":-0.598171,"eighty":-0.316082,"marketCap":6091523},{"date":"2023-05-05","current":-0.60259,"twenty":-1.111365,"median":-0.60259,"eighty":-0.320185,"marketCap":5653199},{"date":"2023-05-12","current":-0.55198,"twenty":-1.103538,"median":-0.60158,"eighty":-0.321514,"marketCap":5686369},{"date":"2023-05-19","current":-0.55198,"twenty":-1.10065,"median":-0.595771,"eighty":-0.327238,"marketCap":5686369},{"date":"2023-05-26","current":-0.505982,"twenty":-1.088059,"median":-0.592742,"eighty":-0.333246,"marketCap":5212505},{"date":"2023-06-02","current":-0.499658,"twenty":-1.08792,"median":-0.589505,"eighty":-0.344867,"marketCap":5147361},{"date":"2023-06-09","current":-0.55704,"twenty":-1.087172,"median":-0.580997,"eighty":-0.350289,"marketCap":5738494},{"date":"2023-06-16","current":-0.620978,"twenty":-1.085644,"median":-0.584704,"eighty":-0.352938,"marketCap":6397166},{"date":"2023-06-23","current":-0.676176,"twenty":-1.085306,"median":-0.589505,"eighty":-0.356472,"marketCap":6965803},{"date":"2023-06-30","current":-0.593264,"twenty":-1.083207,"median":-0.591634,"eighty":-0.359502,"marketCap":6111663},{"date":"2023-07-07","current":-0.517481,"twenty":-1.079536,"median":-0.587708,"eighty":-0.361522,"marketCap":5330971},{"date":"2023-07-14","current":-0.54646,"twenty":-1.077168,"median":-0.582224,"eighty":-0.364046,"marketCap":5629506},{"date":"2023-07-21","current":-0.623853,"twenty":-1.07607,"median":-0.587708,"eighty":-0.366571,"marketCap":6426782},{"date":"2023-07-28","current":-0.721599,"twenty":-1.07607,"median":-0.591634,"eighty":-0.36859,"marketCap":7433744},{"date":"2023-08-04","current":-0.757094,"twenty":-1.073339,"median":-0.593264,"eighty":-0.36859,"marketCap":7374510},{"date":"2023-08-11","current":-0.62027,"twenty":-1.070607,"median":-0.595859,"eighty":-0.371115,"marketCap":6041768},{"date":"2023-08-18","current":-0.543243,"twenty":-1.069577,"median":-0.593625,"eighty":-0.376164,"marketCap":5291483},{"date":"2023-08-25","current":-0.538176,"twenty":-1.067876,"median":-0.592742,"eighty":-0.378689,"marketCap":5242122},{"date":"2023-09-01","current":-0.58277,"twenty":-1.065691,"median":-0.589505,"eighty":-0.378689,"marketCap":5676497},{"date":"2023-09-08","current":-0.590878,"twenty":-1.063086,"median":-0.590829,"eighty":-0.378689,"marketCap":5755475},{"date":"2023-09-15","current":-0.569594,"twenty":-1.061713,"median":-0.58823,"eighty":-0.378689,"marketCap":5548159},{"date":"2023-09-22","current":-0.506757,"twenty":-1.061713,"median":-0.585904,"eighty":-0.378689,"marketCap":4936085},{"date":"2023-09-29","current":-0.433865,"twenty":-1.060727,"median":-0.581611,"eighty":-0.380709,"marketCap":4226078},{"date":"2023-10-06","current":-0.427703,"twenty":-1.05818,"median":-0.578696,"eighty":-0.383738,"marketCap":4166055},{"date":"2023-10-13","current":-0.408953,"twenty":-1.055487,"median":-0.574156,"eighty":-0.383738,"marketCap":3983420},{"date":"2023-10-20","current":-0.41554,"twenty":-1.053848,"median":-0.568243,"eighty":-0.383738,"marketCap":4047589},{"date":"2023-10-27","current":-0.435811,"twenty":-1.053848,"median":-0.56578,"eighty":-0.383738,"marketCap":4245033},{"date":"2023-11-03","current":-0.435811,"twenty":-1.053848,"median":-0.56554,"eighty":-0.384243,"marketCap":4245033},{"date":"2023-11-10","current":-0.411508,"twenty":-1.050251,"median":-0.562656,"eighty":-0.384243,"marketCap":4008308},{"date":"2023-11-17","current":-0.498316,"twenty":-1.046658,"median":-0.560987,"eighty":-0.385884,"marketCap":4304279},{"date":"2023-11-24","current":-0.522671,"twenty":-1.041435,"median":-0.560318,"eighty":-0.386263,"marketCap":4514655},{"date":"2023-12-01","current":-0.568388,"twenty":-1.035221,"median":-0.558953,"eighty":-0.387777,"marketCap":4909543},{"date":"2023-12-08","current":-0.568034,"twenty":-1.0331,"median":-0.560318,"eighty":-0.388787,"marketCap":4906483},{"date":"2023-12-15","current":-0.484601,"twenty":-1.031392,"median":-0.558953,"eighty":-0.389637,"marketCap":4185812},{"date":"2023-12-22","current":-0.477732,"twenty":-1.021693,"median":-0.557743,"eighty":-0.390868,"marketCap":4126480},{"date":"2023-12-29","current":-0.588241,"twenty":-1.014712,"median":-0.55704,"eighty":-0.391312,"marketCap":5081023},{"date":"2024-01-05","current":-0.532603,"twenty":-1.010893,"median":-0.55589,"eighty":-0.391312,"marketCap":4600445},{"date":"2024-01-12","current":-0.526889,"twenty":-1.007253,"median":-0.553378,"eighty":-0.393331,"marketCap":4551084},{"date":"2024-01-19","current":-0.454873,"twenty":-1.0057,"median":-0.55198,"eighty":-0.393836,"marketCap":3929036},{"date":"2024-01-26","current":-0.427454,"twenty":-1.003464,"median":-0.551802,"eighty":-0.393836,"marketCap":3692202},{"date":"2024-02-02","current":-0.394309,"twenty":-1.000719,"median":-0.549335,"eighty":-0.39412,"marketCap":3405909},{"date":"2024-02-09","current":-0.38288,"twenty":-0.99632,"median":-0.548588,"eighty":-0.392826,"marketCap":3307187},{"date":"2024-02-16","current":-0.318876,"twenty":-0.989219,"median":-0.547495,"eighty":-0.388787,"marketCap":2754343},{"date":"2024-02-23","current":-0.301732,"twenty":-0.98485,"median":-0.546977,"eighty":-0.385127,"marketCap":2606260},{"date":"2024-03-01","current":-0.314316,"twenty":-0.983153,"median":-0.545642,"eighty":-0.383738,"marketCap":2714953},{"date":"2024-03-08","current":-0.135997,"twenty":-0.983067,"median":-0.543349,"eighty":-0.379908,"marketCap":1174693},{"date":"2024-03-15","current":-0.20704,"twenty":-0.982596,"median":-0.542611,"eighty":-0.378689,"marketCap":1798470},{"date":"2024-03-22","current":-0.381897,"twenty":-0.979215,"median":-0.541631,"eighty":-0.378689,"marketCap":3317373},{"date":"2024-03-28","current":-0.369167,"twenty":-0.97426,"median":-0.540481,"eighty":-0.37767,"marketCap":3206793},{"date":"2024-04-05","current":-0.364923,"twenty":-0.969858,"median":-0.539696,"eighty":-0.377263,"marketCap":3169934},{"date":"2024-04-12","current":-0.326734,"twenty":-0.967338,"median":-0.538176,"eighty":-0.369557,"marketCap":2838196},{"date":"2024-04-19","current":-0.305517,"twenty":-0.96715,"median":-0.536661,"eighty":-0.365152,"marketCap":2653898},{"date":"2024-04-26","current":-0.267328,"twenty":-0.964085,"median":-0.533552,"eighty":-0.358997,"marketCap":2322161},{"date":"2024-05-03","current":-0.309761,"twenty":-0.95419,"median":-0.531461,"eighty":-0.351423,"marketCap":2690758},{"date":"2024-05-10","current":-0.337342,"twenty":-0.951156,"median":-0.528981,"eighty":-0.340821,"marketCap":2930346},{"date":"2024-05-17","current":-0.367202,"twenty":-0.948223,"median":-0.527946,"eighty":-0.340821,"marketCap":3088456},{"date":"2024-05-24","current":-0.34075,"twenty":-0.943728,"median":-0.525421,"eighty":-0.340947,"marketCap":2865976},{"date":"2024-05-31","current":-0.331712,"twenty":-0.943659,"median":-0.525,"eighty":-0.340592,"marketCap":2789958},{"date":"2024-06-07","current":-0.346334,"twenty":-0.928015,"median":-0.523469,"eighty":-0.340703,"marketCap":2912940},{"date":"2024-06-14","current":-0.340703,"twenty":-0.926289,"median":-0.522398,"eighty":-0.340681,"marketCap":2865578},{"date":"2024-06-21","current":-0.295228,"twenty":-0.922433,"median":-0.519905,"eighty":-0.336816,"marketCap":2483103},{"date":"2024-06-28","current":-0.279187,"twenty":-0.920151,"median":-0.518004,"eighty":-0.336018,"marketCap":2348182},{"date":"2024-07-05","current":-0.274313,"twenty":-0.920151,"median":-0.512285,"eighty":-0.333064,"marketCap":2307188},{"date":"2024-07-12","current":-0.307579,"twenty":-0.914702,"median":-0.509745,"eighty":-0.331195,"marketCap":2586980},{"date":"2024-07-15","current":-0.310418,"twenty":-0.91334,"median":-0.508665,"eighty":-0.331019,"marketCap":2610860},{"date":"2024-08-02","current":-0.272562,"twenty":-0.913129,"median":-0.507585,"eighty":-0.329729,"marketCap":2292462},{"date":"2024-08-09","current":-0.248051,"twenty":-0.911177,"median":-0.505359,"eighty":-0.325114,"marketCap":2086300},{"date":"2024-08-16","current":-0.24035,"twenty":-0.906543,"median":-0.501744,"eighty":-0.319687,"marketCap":1989587},{"date":"2024-08-23","current":-0.293286,"twenty":-0.905493,"median":-0.497744,"eighty":-0.316091,"marketCap":2427781},{"date":"2024-08-30","current":-0.286555,"twenty":-0.903919,"median":-0.49203,"eighty":-0.313322,"marketCap":2372062},{"date":"2024-09-06","current":-0.383339,"twenty":-0.901905,"median":-0.490945,"eighty":-0.313073,"marketCap":3173230},{"date":"2024-09-13","current":-0.311556,"twenty":-0.894391,"median":-0.486542,"eighty":-0.313073,"marketCap":2579020},{"date":"2024-09-20","current":-0.276506,"twenty":-0.893083,"median":-0.485429,"eighty":-0.309761,"marketCap":2288880},{"date":"2024-09-27","current":-0.252418,"twenty":-0.880828,"median":-0.484661,"eighty":-0.307436,"marketCap":2089484},{"date":"2024-10-04","current":-0.23434,"twenty":-0.872964,"median":-0.484601,"eighty":-0.302929,"marketCap":1939837},{"date":"2024-10-11","current":-0.252827,"twenty":-0.865099,"median":-0.482434,"eighty":-0.301027,"marketCap":2092867},{"date":"2024-10-18","current":-0.317326,"twenty":-0.857235,"median":-0.47841,"eighty":-0.300426,"marketCap":2626780},{"date":"2024-10-25","current":-0.39995,"twenty":-0.857235,"median":-0.476537,"eighty":-0.300426,"marketCap":3310734},{"date":"2024-10-31","current":-0.494182,"twenty":-0.850943,"median":-0.478071,"eighty":-0.300907,"marketCap":4090778},{"date":"2024-11-08","current":-0.422626,"twenty":-0.840642,"median":-0.476351,"eighty":-0.301191,"marketCap":3498446},{"date":"2024-11-15","current":-0.352287,"twenty":-0.834605,"median":-0.468894,"eighty":-0.301334,"marketCap":3065275},{"date":"2024-11-22","current":-0.359821,"twenty":-0.830942,"median":-0.464302,"eighty":-0.301657,"marketCap":3130826},{"date":"2024-11-29","current":-0.348213,"twenty":-0.815329,"median":-0.462,"eighty":-0.30245,"marketCap":3029832},{"date":"2024-12-06","current":-0.435267,"twenty":-0.804556,"median":-0.461782,"eighty":-0.30359,"marketCap":3787290},{"date":"2024-12-13","current":-0.420758,"twenty":-0.775862,"median":-0.460599,"eighty":-0.304922,"marketCap":3661047},{"date":"2024-12-20","current":-0.375374,"twenty":-0.755346,"median":-0.458782,"eighty":-0.305517,"marketCap":3266158},{"date":"2024-12-27","current":-0.324419,"twenty":-0.754181,"median":-0.457684,"eighty":-0.304625,"marketCap":2822793},{"date":"2025-01-03","current":-0.389709,"twenty":-0.753938,"median":-0.457139,"eighty":-0.305517,"marketCap":3390886},{"date":"2025-01-10","current":-0.36162,"twenty":-0.752966,"median":-0.455912,"eighty":-0.305517,"marketCap":3146480},{"date":"2025-01-17","current":-0.342177,"twenty":-0.750208,"median":-0.452331,"eighty":-0.307436,"marketCap":2977309},{"date":"2025-01-24","current":-0.238758,"twenty":-0.74342,"median":-0.451013,"eighty":-0.307052,"marketCap":2077454},{"date":"2025-01-31","current":-0.167665,"twenty":-0.737124,"median":-0.449377,"eighty":-0.30269,"marketCap":1458864},{"date":"2025-02-07","current":-0.757086,"twenty":-0.737124,"median":-0.448569,"eighty":-0.301334,"marketCap":6587465},{"date":"2025-02-14","current":-0.783111,"twenty":-0.74342,"median":-0.449855,"eighty":-0.301657,"marketCap":6813909},{"date":"2025-02-21","current":-0.78737,"twenty":-0.751311,"median":-0.451168,"eighty":-0.30245,"marketCap":6850964},{"date":"2025-02-28","current":-0.840366,"twenty":-0.753452,"median":-0.452677,"eighty":-0.30359,"marketCap":7312086},{"date":"2025-03-07","current":-0.710242,"twenty":-0.753452,"median":-0.457022,"eighty":-0.304922,"marketCap":6179866},{"date":"2025-03-14","current":-0.697939,"twenty":-0.751311,"median":-0.45752,"eighty":-0.305517,"marketCap":6072819},{"date":"2025-03-21","current":-0.666099,"twenty":-0.746669,"median":-0.458782,"eighty":-0.306668,"marketCap":5969890},{"date":"2025-03-28","current":-0.654614,"twenty":-0.742758,"median":-0.460599,"eighty":-0.307522,"marketCap":5866961},{"date":"2025-04-04","current":-0.597422,"twenty":-0.741572,"median":-0.462322,"eighty":-0.30825,"marketCap":5354374},{"date":"2025-04-11","current":-0.360284,"twenty":-0.741572,"median":-0.462,"eighty":-0.309143,"marketCap":3229031},{"date":"2025-04-17","current":-0.393753,"twenty":-0.739272,"median":-0.460599,"eighty":-0.309568,"marketCap":3528996},{"date":"2025-04-25","current":-0.435271,"twenty":-0.735618,"median":-0.459466,"eighty":-0.310024,"marketCap":3901103},{"date":"2025-05-02","current":-0.433456,"twenty":-0.734421,"median":-0.458108,"eighty":-0.310681,"marketCap":3884836},{"date":"2025-05-09","current":-0.410992,"twenty":-0.733427,"median":-0.457352,"eighty":-0.311268,"marketCap":3683507},{"date":"2025-05-16","current":-0.433495,"twenty":-0.733238,"median":-0.456951,"eighty":-0.312163,"marketCap":4528878},{"date":"2025-05-23","current":-0.476844,"twenty":-0.73159,"median":-0.457022,"eighty":-0.313182,"marketCap":4981766},{"date":"2025-05-30","current":-0.510623,"twenty":-0.72928,"median":-0.457352,"eighty":-0.313539,"marketCap":5334665},{"date":"2025-06-06","current":-0.492889,"twenty":-0.726897,"median":-0.458108,"eighty":-0.314338,"marketCap":5149393},{"date":"2025-06-13","current":-0.476844,"twenty":-0.721599,"median":-0.460002,"eighty":-0.314632,"marketCap":4981766},{"date":"2025-06-20","current":-0.472762,"twenty":-0.721599,"median":-0.461082,"eighty":-0.315448,"marketCap":4939123},{"date":"2025-06-27","current":-0.547779,"twenty":-0.720641,"median":-0.462644,"eighty":-0.316082,"marketCap":5722855},{"date":"2025-07-03","current":-0.495422,"twenty":-0.717621,"median":-0.464343,"eighty":-0.316116,"marketCap":5175860},{"date":"2025-07-11","current":-0.507256,"twenty":-0.713373,"median":-0.4685,"eighty":-0.316507,"marketCap":5299493},{"date":"2025-07-18","current":-0.492044,"twenty":-0.712018,"median":-0.468907,"eighty":-0.317181,"marketCap":5140570},{"date":"2025-07-25","current":-0.481629,"twenty":-0.711655,"median":-0.470834,"eighty":-0.318566,"marketCap":5031760},{"date":"2025-08-01","current":-0.377197,"twenty":-0.710512,"median":-0.468907,"eighty":-0.319132,"marketCap":3940712},{"date":"2025-08-08","current":-0.389019,"twenty":-0.709863,"median":-0.4685,"eighty":-0.31949,"marketCap":4064227},{"date":"2025-08-15","current":-0.353066,"twenty":-0.70693,"median":-0.464343,"eighty":-0.320061,"marketCap":4296552},{"date":"2025-08-22","current":-0.351906,"twenty":-0.703381,"median":-0.462322,"eighty":-0.321248,"marketCap":4282436},{"date":"2025-08-29","current":-0.36249,"twenty":-0.700976,"median":-0.460599,"eighty":-0.322147,"marketCap":4411245},{"date":"2025-09-05","current":-0.368517,"twenty":-0.699677,"median":-0.459955,"eighty":-0.323573,"marketCap":4484589},{"date":"2025-09-12","current":-0.364907,"twenty":-0.698401,"median":-0.459424,"eighty":-0.324593,"marketCap":4440653},{"date":"2025-09-19","current":-0.386656,"twenty":-0.697939,"median":-0.457848,"eighty":-0.325298,"marketCap":4705328},{"date":"2025-09-26","current":-0.35814,"twenty":-0.697858,"median":-0.457139,"eighty":-0.326095,"marketCap":4358310},{"date":"2025-10-03","current":-0.353066,"twenty":-0.694336,"median":-0.454873,"eighty":-0.326416,"marketCap":4296552},{"date":"2025-10-10","current":-0.394389,"twenty":-0.691173,"median":-0.452245,"eighty":-0.32662,"marketCap":4799434},{"date":"2025-10-17","current":-0.654416,"twenty":-0.697858,"median":-0.454873,"eighty":-0.32682,"marketCap":7963767},{"date":"2025-10-24","current":-0.647649,"twenty":-0.698401,"median":-0.457139,"eighty":-0.327094,"marketCap":7881424},{"date":"2025-10-31","current":-0.566171,"twenty":-0.697939,"median":-0.457848,"eighty":-0.328539,"marketCap":6889891},{"date":"2025-11-07","current":-0.424876,"twenty":-0.697858,"median":-0.45875,"eighty":-0.329896,"marketCap":5170435},{"date":"2025-11-14","current":-0.817796,"twenty":-0.698401,"median":-0.459476,"eighty":-0.3307,"marketCap":11259057},{"date":"2025-11-21","current":-1.122489,"twenty":-0.704091,"median":-0.460563,"eighty":-0.331151,"marketCap":15453937},{"date":"2025-11-28","current":-1.325415,"twenty":-0.711053,"median":-0.461782,"eighty":-0.331323,"marketCap":18247728},{"date":"2025-12-05","current":-1.152349,"twenty":-0.717675,"median":-0.464302,"eighty":-0.331469,"marketCap":15865036},{"date":"2025-12-12","current":-0.692263,"twenty":-0.721216,"median":-0.467711,"eighty":-0.331585,"marketCap":9530767},{"date":"2025-12-19","current":-0.842172,"twenty":-0.721599,"median":-0.46888,"eighty":-0.33172,"marketCap":11594648},{"date":"2025-12-26","current":-0.847047,"twenty":-0.72928,"median":-0.468962,"eighty":-0.331777,"marketCap":11661766},{"date":"2026-01-02","current":-0.879344,"twenty":-0.733427,"median":-0.471638,"eighty":-0.331963,"marketCap":12106423},{"date":"2026-01-09","current":-0.801343,"twenty":-0.736748,"median":-0.472832,"eighty":-0.332335,"marketCap":11032534},{"date":"2026-01-16","current":-0.649606,"twenty":-0.736748,"median":-0.475311,"eighty":-0.333246,"marketCap":8943484},{"date":"2026-01-23","current":-0.588667,"twenty":-0.736748,"median":-0.476722,"eighty":-0.334203,"marketCap":8104508},{"date":"2026-01-30","current":-0.505791,"twenty":-0.736129,"median":-0.476844,"eighty":-0.335031,"marketCap":6963500},{"date":"2026-02-06","current":-0.47654,"twenty":-0.735261,"median":-0.476844,"eighty":-0.33585,"marketCap":6560792},{"date":"2026-02-13","current":-0.503962,"twenty":-0.733758,"median":-0.476783,"eighty":-0.336018,"marketCap":6938331},{"date":"2026-02-20","current":-0.571604,"twenty":-0.733427,"median":-0.476844,"eighty":-0.336023,"marketCap":7869594},{"date":"2026-02-27","current":-0.518588,"twenty":-0.733143,"median":-0.477407,"eighty":-0.336816,"marketCap":7139685},{"date":"2026-03-06","current":-1.048021,"twenty":-0.733427,"median":-0.47819,"eighty":-0.338102,"marketCap":14428683},{"date":"2026-03-13","current":-0.989322,"twenty":-0.736748,"median":-0.478533,"eighty":-0.338728,"marketCap":13620542},{"date":"2026-03-20","current":-1.010111,"twenty":-0.742658,"median":-0.479947,"eighty":-0.339098,"marketCap":13906759},{"date":"2026-03-27","current":-0.805879,"twenty":-0.753452,"median":-0.481629,"eighty":-0.339386,"marketCap":12736638},{"date":"2026-04-02","current":-0.645555,"twenty":-0.754181,"median":-0.482671,"eighty":-0.339473,"marketCap":10202779},{"date":"2026-04-10","current":-0.655048,"twenty":-0.754181,"median":-0.484263,"eighty":-0.339808,"marketCap":10352813},{"date":"2026-04-17","current":-0.750909,"twenty":-0.753695,"median":-0.484601,"eighty":-0.340345,"marketCap":11867859},{"date":"2026-04-24","current":-0.653907,"twenty":-0.752143,"median":-0.484722,"eighty":-0.340522,"marketCap":10334776},{"date":"2026-05-01","current":-0.739497,"twenty":-0.750629,"median":-0.485839,"eighty":-0.340636,"marketCap":11687496},{"date":"2026-05-08","current":-0.726944,"twenty":-0.747849,"median":-0.486634,"eighty":-0.340703,"marketCap":11489097},{"date":"2026-05-15","current":-0.616771,"twenty":-0.74421,"median":-0.488728,"eighty":-0.340703,"marketCap":10479067},{"date":"2026-05-22","current":-0.51486,"twenty":-0.743126,"median":-0.48955,"eighty":-0.340718,"marketCap":8747586},{"date":"2026-05-29","current":-0.524414,"twenty":-0.741673,"median":-0.490945,"eighty":-0.340743,"marketCap":8909912},{"date":"2026-06-05","current":-0.455413,"twenty":-0.741304,"median":-0.490945,"eighty":-0.340807,"marketCap":7737555},{"date":"2026-06-12","current":-0.498937,"twenty":-0.74041,"median":-0.490945,"eighty":-0.341072,"marketCap":8477042},{"date":"2026-06-18","current":-0.546131,"twenty":-0.739497,"median":-0.491213,"eighty":-0.341224,"marketCap":9278886},{"date":"2026-06-26","current":-0.496483,"twenty":-0.73803,"median":-0.491481,"eighty":-0.341735,"marketCap":8435351},{"date":"2026-07-02","current":-0.55677,"twenty":-0.737378,"median":-0.492044,"eighty":-0.342089,"marketCap":9459644},{"date":"2026-07-10","current":-0.552042,"twenty":-0.736841,"median":-0.492895,"eighty":-0.342178,"marketCap":9379307},{"date":"2026-07-17","current":-0.491755,"twenty":-0.736748,"median":-0.493447,"eighty":-0.343435,"marketCap":8355014},{"date":"2026-07-24","current":-0.516579,"twenty":-0.736129,"median":-0.495,"eighty":-0.344984,"marketCap":8776782},{"date":"2026-07-31","current":-0.520125,"twenty":-0.735439,"median":-0.495731,"eighty":-0.345304,"marketCap":8837034},{"date":"2026-08-07","current":-0.540221,"twenty":-0.734992,"median":-0.496483,"eighty":-0.345469,"marketCap":9178465},{"date":"2026-08-14","current":-0.715172,"twenty":-0.734247,"median":-0.497419,"eighty":-0.345574,"marketCap":12150922},{"date":"2026-08-21","current":-0.536932,"twenty":-0.733573,"median":-0.498316,"eighty":-0.345799,"marketCap":10022000},{"date":"2026-08-28","current":-0.554686,"twenty":-0.733427,"median":-0.499372,"eighty":-0.34618,"marketCap":10353389}],"updateTime":1788207574476},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QNRX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630588449","title":"Quoin Pharmaceuticals Provides Clinical And Regulatory Update For Qrx009 Topical Rapamycin Development Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2630588449","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630588449?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:55","pubTimestamp":1777384522,"startTime":"0","endTime":"0","summary":"April 28 (Reuters) - Quoin Pharmaceuticals Ltd <2EB0y.F>::*QUOIN PHARMACEUTICALS PROVIDES CLINICAL AND REGULATORY UPDATE FOR QRX009 TOPICAL RAPAMYCIN DEVELOPMENT PROGRAMS*QUOIN PHARMACEUTICALS LTD - T","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nRSD2DHyyQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630047183","title":"Quoin plans investigator-led trial of QRX009 topical rapamycin in pachyonychia congenita","url":"https://stock-news.laohu8.com/highlight/detail?id=2630047183","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630047183?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:35","pubTimestamp":1777379739,"startTime":"0","endTime":"0","summary":"Quoin outlined plans to launch several investigator-led clinical studies for QRX009 topical rapamycin, with no trial results presented to date.First study targets pachyonychia congenita, with initiation targeted for Q3 2026.Additional investigator-led studies in Gorlin syndrome and tuberous sclerosis complex are planned later in 2026 to broaden QRX009 clinical readouts.Regulatory strategy includes filing an FDA investigational new drug application for QRX009 in an additional indication in Q3 2026.Management expects QRX009 could be in active testing across four indications before end-2026, positioning it as a pipeline expansion alongside ongoing late-stage work in Netherton syndrome.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quoin ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL8rmx47:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630472304","title":"Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2630472304","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630472304?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:30","pubTimestamp":1777379400,"startTime":"0","endTime":"0","summary":"Company Planning Multi-Pronged Approach for QRX009 Including Several Investigator Led Clinical Studies in Key Indications.  Company to Initiate Investigator Led Clinical Study in Pachyonychia Congenit","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/28/3282671/0/en/Quoin-Pharmaceuticals-Provides-Clinical-and-Regulatory-Update-for-QRX009-Topical-Rapamycin-Development-Programs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2471134879.HKD","LU2750360997.AUD","BK4588","BK4533","LU2237443895.HKD","LU2471134952.CNY","LU1868836914.USD","IE0004086264.USD","LU1894683264.USD","LU0061475181.USD","IE00B19Z3581.USD","LU1894683348.USD","BK4504","LU1868836757.USD","LU2237438978.USD","BK4552","LU1668664300.SGD","QNRX","BK4516","LU2750360641.GBP","BK4209","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU0048573561.USD","LU2237443978.SGD","LU1868837300.USD","LU1791807156.HKD","LU0106831901.USD","BK4550","BK4139","LU0251131958.USD","IND","LU2471134796.USD","IE0004091025.USD","BK4127","IE00BFXG1179.USD","LU0345770993.USD","LU2237443622.USD","LU2265009873.SGD","PC","LU0345770308.USD","LU2237443382.USD","LU0251142724.SGD","LU1868837136.USD","LU1868836591.USD","LU2237443549.SGD","IE0034235188.USD","BK4585","LU1804176565.USD","GSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629005608","title":"Quoin’s QRX003 Trial Moves Forward In Rare Skin Disease, Keeping QNRX On Investor Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2629005608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629005608?lang=en_us&edition=fundamental","pubTime":"2026-04-22 00:31","pubTimestamp":1776789083,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd ($QNRX) announced an update on their ongoing clinical study. The multicenter study “A Multicenter, Open-label Study of QR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoins-qrx003-trial-moves-forward-in-rare-skin-disease-keeping-qnrx-on-investor-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoins-qrx003-trial-moves-forward-in-rare-skin-disease-keeping-qnrx-on-investor-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622961388","title":"Financing Covenants Put Quoin Pharmaceuticals at Heightened Risk of Funding Shortfall and Program Delays","url":"https://stock-news.laohu8.com/highlight/detail?id=2622961388","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622961388?lang=en_us&edition=fundamental","pubTime":"2026-03-28 14:00","pubTimestamp":1774677650,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd (QNRX) has disclosed a new risk, in the Debt & Financing category. Quoin Pharmaceuticals Ltd. faces heightened financing ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/financing-covenants-put-quoin-pharmaceuticals-at-heightened-risk-of-funding-shortfall-and-program-delays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/financing-covenants-put-quoin-pharmaceuticals-at-heightened-risk-of-funding-shortfall-and-program-delays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622082337","title":"Quoin Pharmaceuticals Ltd : Alliance Global Partners Raises Target Price to $35 From $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2622082337","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622082337?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:03","pubTimestamp":1774609386,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622866806","title":"Quoin Pharmaceuticals Ltd reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2622866806","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622866806?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:09","pubTimestamp":1774534181,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd reports results for the quarter ended December 31 - Earnings SummaryQuoin Pharmaceuticals Ltd QNRX.OQ reported a quarterly adjusted loss of $14.80 per share for the quarter e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nL8N40E1FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622985779","title":"Quoin Pharmaceuticals Q4 EPS $(1.74) Beats $(4.02) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2622985779","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622985779?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:32","pubTimestamp":1774528331,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.74) per share which beat the analyst consensus estimate of $(4.02) by 56.72 percent. This is a 85.96 percent increase over losses of $(12.39) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51479392/quoin-pharmaceuticals-q4-eps-1-74-beats-4-02-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622570558","title":"Quoin Pharmaceuticals FY2025 net loss widens 76.34% to $15.8 million; cash climbs 14.85% to $18.7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622570558","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622570558?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:31","pubTimestamp":1774528291,"startTime":"0","endTime":"0","summary":"Quoin published a press release providing a corporate update and reporting fourth-quarter and full-year 2025 financial results.Net loss widened to USD 4.3 million in Q4 2025, and to USD 15.8 million for FY 2025.Research and development expense rose to USD 9.8 million for FY 2025, nearly tripling, while general and administrative expense increased to USD 6.5 million, up 9.5%.Cash, cash equivalents and marketable securities totaled USD 18.7 million at year-end 2025, and Quoin said this is expected to fund operations into 2027.Michael Myers said the company is preparing to initiate a Phase 3 study for QRX003 in Netherton syndrome in 2026 and is targeting an NDA filing in 2027, with topline data from two whole-body Netherton syndrome trials expected in the second half of 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL64PZGH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","BK4139","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU2210149790.SGD","LU2095319765.USD","LU2210150020.SGD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014013.SGD","QNRX","BK4585","SG9999014021.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622857777","title":"Press Release: Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622857777","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622857777?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:30","pubTimestamp":1774528200,"startTime":"0","endTime":"0","summary":"-- Closes Private Placement Financing of Up to $104.5 Million. -- Secures Orphan Drug Designations for QRX003 for Netherton Syndrome  in the U.S. and Europe. -- Advances Proposed Expedited Regulatory Approval Pathways in Japan and Saudi Arabia and Secures Fast Track Designation in the U.S. for QRX003 for NS Subsequent to the End of Q4. -- Reports Continued Clinical Progress for QRX003 in Netherton Syndrome Clinical Studies including Data Supporting Longer Term Durable Treatment Effect and Safety Profile. -- Pediatric NS Study Expanded to 7 Children Now Actively Treated with QRX003, Largest Cohort of This Age Group Ever Studied. -- Ongoing Clinical Data Continues to Support Development of QRX003 as a Treatment for Peeling Skin Syndrome with Study Being Expanded to 6 Subjects. -- Proprietary Rapamycin Topical Platforms Achieve Target Loadings; Clinical Studies Planned in 2H 2026. -- NETHERTON NOW Awareness Campaign Surpasses 2 Million Video Views and 24 Million Global Impressions. ASHBUR","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","LABU","BK4588","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622851232","title":"Market Sentiment Around Loss-Making Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622851232","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622851232?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:14","pubTimestamp":1774520089,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals, Ltd. ( NASDAQ:QNRX ) is possibly approaching a major achievement in its business, so we would...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qnrx/quoin-pharmaceuticals/news/market-sentiment-around-loss-making-quoin-pharmaceuticals-lt","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qnrx/quoin-pharmaceuticals/news/market-sentiment-around-loss-making-quoin-pharmaceuticals-lt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QQQE","JEPQ","GPIQ","NVIW.SI","QLD","NQmain","QQQJ","TQQQ",".IXIC","PSQ","QNRX","SQQQ","BK4139","FTEC","MNQmain","QQQY","QID","QDTE","IYW","QYLG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622071996","title":"Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2622071996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622071996?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:35","pubTimestamp":1774445756,"startTime":"0","endTime":"0","summary":"09:33 EDT Quoin Pharmaceuticals (QNRX) Ltd – ADR trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-ltd-adr-trading-halted-volatility-trading-pause-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-ltd-adr-trading-halted-volatility-trading-pause-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622713970","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:33 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2622713970","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622713970?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:33","pubTimestamp":1774445595,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:33 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nAQN2LRNWA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622907633","title":"Quoin Pharmaceuticals Provides Clinical And Regulatory Update From Constructive Type C Meeting With U.S. FDA For Qrx003 In Netherton Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2622907633","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622907633?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:44","pubTimestamp":1774442692,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd <2EB0y.F>::*QUOIN PHARMACEUTICALS PROVIDES CLINICAL AND REGULATORY UPDATE FROM CONSTRUCTIVE TYPE C MEETING WITH U.S. FDA FOR QRX003 IN NETHERTON SYNDROME*QUOIN PHARMACEUTICAL","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nRSD7GDgvZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622075456","title":"Quoin Pharmaceuticals rises on FDA feedback; single Phase 3 trial may support QRX003 approval in Netherton syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2622075456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622075456?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:31","pubTimestamp":1774441900,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals said the U.S. FDA indicated that a single Phase 3 study may be sufficient to support marketing approval for QRX003 in Netherton Syndrome.The FDA expressed openness to an alternative Phase 3 design, such as a randomized withdrawal or randomized delayed start study, that would likely not include a traditional upfront vehicle or placebo control.The company plans to submit clinical data from its ongoing Phase 2 and pediatric investigator studies and request a meeting to discuss the data before starting the Phase 3 pivotal program.Quoin Pharmaceuticals said it remains on track to initiate Phase 3 and complete Phase 3 patient recruitment in 2026, and it could file for NDA approval in 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDLb8sLSF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621062180","title":"Quoin Pharmaceuticals Ltd  expected to post a loss of $3.34 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2621062180","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621062180?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:35","pubTimestamp":1774355704,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd  expected to post a loss of $3.34 a share - Earnings Preview Quoin Pharmaceuticals Ltd QNRX.OQ, QNRX.O is expected to  show no change in quarterly revenue when it reports  re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nL8N40C1DD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620285832","title":"Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620285832","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620285832?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:30","pubTimestamp":1773923400,"startTime":"0","endTime":"0","summary":"ASHBURN, Va., March  19, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the \"Company\" or \"Quoin\"), a late clinical-stage specialty pharmaceutical company focused on rare and orpha","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3258994/0/en/Quoin-Pharmaceuticals-to-Announce-Corporate-Update-and-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-Thursday-March-26-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618976323","title":"Quoin Pharmaceuticals begins two late-stage whole-body trials of QRX003 4% lotion for Netherton Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2618976323","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618976323?lang=en_us&edition=fundamental","pubTime":"2026-03-12 04:57","pubTimestamp":1773262667,"startTime":"0","endTime":"0","summary":"Quoin said the FDA granted Fast Track designation to QRX003 lotion (4%) for treating Netherton syndrome. QRX003 is being evaluated in two late-stage whole-body clinical trials designed to assess safety and efficacy in patients with Netherton syndrome. The company did not report clinical results in the announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quoin Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL9qkBHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618947659","title":"Quoin Pharmaceuticals receives U.S. Fast Track Designation to QRX003","url":"https://stock-news.laohu8.com/highlight/detail?id=2618947659","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618947659?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:38","pubTimestamp":1773232725,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced that the U.S. Food and Drug Administration has granted Fast Track Designation to QRX003 lotion for the treat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-receives-u-s-fast-track-designation-to-qrx003-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-receives-u-s-fast-track-designation-to-qrx003-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618748942","title":"FDA grants Fast Track designation to Quoin's QRX003 for Netherton syndrome treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2618748942","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618748942?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:30","pubTimestamp":1773232223,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals said the U.S. FDA granted Fast Track designation to its QRX003 lotion (4%) for Netherton Syndrome, a regulatory status intended to speed development and potentially accelerate review. The company noted QRX003 previously received FDA Pediatric Rare Disease and Orphan Drug designations, and EMA Orphan Drug designation, which can provide incentives such as market exclusivity upon approval, tax credits and fee reductions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL2NZgz0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BGHQF748.EUR","BK4112","NDAQ","BK4585","BK4139","BK4588","LU2210149790.SGD","LU0314104364.USD","IE00B64PRP62.GBP","QNRX","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014039.USD","IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":61,"code":"91000000","status":"200"}]}}